Wed-08-10-2014, 16:10 PM
This is great news a biosimilar coming to fruition the study results are very reassuring as compared to Humira..
So will this mean a reduction in cost when it is released ? I very much doubt it. But would like to think positively about these companies.
My question is when these studies finish do the study recipients carry on with the treatment if successful or do they have to come off it and go back to something else?
So will this mean a reduction in cost when it is released ? I very much doubt it. But would like to think positively about these companies.
My question is when these studies finish do the study recipients carry on with the treatment if successful or do they have to come off it and go back to something else?